{"version":"1.0","provider_name":"Funds Society","provider_url":"https:\/\/www.fundssociety.com\/es\/","title":"Invertir en la pr\u00f3xima oleada de medicamentos innovadores - Funds Society","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"a6FzTb0jqW\"><a href=\"https:\/\/www.fundssociety.com\/es\/eventos\/invertir-proxima-oleada-medicamentos-innovadores\/\">Invertir en la pr\u00f3xima oleada de medicamentos innovadores<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.fundssociety.com\/es\/eventos\/invertir-proxima-oleada-medicamentos-innovadores\/embed\/#?secret=a6FzTb0jqW\" width=\"600\" height=\"338\" title=\"\u00abInvertir en la pr\u00f3xima oleada de medicamentos innovadores\u00bb \u2014 Funds Society\" data-secret=\"a6FzTb0jqW\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.fundssociety.com\/wp-content\/uploads\/2022\/07\/Towfiqu-Barbhuiya-healthcare-pills_0.JPG","thumbnail_width":878,"thumbnail_height":575,"description":"El sector sanitario est\u00e1 logrando avances notables en categor\u00edas de enfermedades que antes ten\u00edan opciones de tratamiento limitadas, como la EHNA, una de las principales causas de insuficiencia hep\u00e1tica.\u00a0 Janus Henderson Investors celebrar\u00e1 el pr\u00f3ximo 4 de mayo un webcast en el que se hablar\u00e1 en detalle de los avances cient\u00edficos que se est\u00e1n produciendo&hellip;Continuar leyendo"}